Source:http://linkedlifedata.com/resource/pubmed/id/11499050
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-8-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
H
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0015-8259
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
118-22, 126, 130-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11499050-Antidepressive Agents, Second-Generation,
pubmed-meshheading:11499050-Drug Costs,
pubmed-meshheading:11499050-Drug Industry,
pubmed-meshheading:11499050-Drugs, Generic,
pubmed-meshheading:11499050-Economic Competition,
pubmed-meshheading:11499050-Fluoxetine,
pubmed-meshheading:11499050-Humans,
pubmed-meshheading:11499050-United States
|
pubmed:year |
2001
|
pubmed:articleTitle |
Prozac. A bitter pill.
|
pubmed:publicationType |
News
|